Guha, I. N.; Parkes, J..; Roderick, P. R.; Harris, S.; Rosenberg, W. M.
November 2006
Gut;Nov2006, Vol. 55 Issue 11, p1650
Academic Journal
The diagnosis of fibrosis within liver disease is important for prognosis, stratification for treatment, and monitoring of treatment efficacy. The rising incidence and prevalence of non-alcoholic fatty liver disease (NAFLD) has driven the search for accurate non-invasive tools of liver fibrosis within this condition. With the aid of a systematic review, we explore how the field has evolved from the discovery of simple blood parameters to panel markers of liver fibrosis. We will discuss the biological plausibility, limitations, potential uses, and emerging diagnostic techniques of non-invasive markers in this rapidly expanding field.


Related Articles

  • Nonalcoholic Fatty Liver Disease: Pros and Cons of Histologic Systems of Evaluation. Brunt, Elizabeth M. // International Journal of Molecular Sciences;2016, Vol. 17 Issue 1, p1 

    The diagnostic phenotype of nonalcoholic fatty liver disease (NAFLD)—in particular, the most significant form in terms of prognosis, nonalcoholic steatohepatitis (NASH)—continues to rely on liver tissue evaluation, in spite of remarkable advances in non-invasive algorithms...

  • Direct comparison of the FibroScan XL and M probes for assessment of liver fibrosis in obese and nonobese patients. Durango, Esteban; Dietrich, Christian; Seitz, Helmut Karl; Kunz, Cornelia Ursula; Pomier-Layrargues, Gilles T.; Duarte-Rojo, Andres; Beaton, Melanie; Elkhashab, Magdy; Myers, Robert P.; Mueller, Sebastian // Hepatic Medicine: Evidence & Research;2013, Vol. 5, p43 

    Background: A novel Fibroscan XL probe has recently been introduced and validated for obese patients, and has a diagnostic accuracy comparable with that of the standard M probe. The aim of this study was to analyze and understand the differences between these two probes in nonobese patients, to...

  • Non-alcoholic fatty liver disease: what's new under the microscope? Brunt, Elizabeth M. // Gut;Aug2011, Vol. 60 Issue 8, p1152 

    Pathologist's observations have remained central to the evolution of the field of non-alcoholic fatty liver disease, even with the advent of increasingly effective non-invasive markers of advanced fibrosis. As the field matures, the role of pathology has also shifted from being largely...

  • Is transient elastography a useful tool for screening liver disease? Del Poggio, Paolo; Colombo, Silvia; Castellote, Jose // World Journal of Gastroenterology;3/28/2009, Vol. 15 Issue 12, p1409 

    Transient elastography (TE) is a new non invasive tool for measuring liver stiffness, which is correlated to the histologic stage of liver fibrosis. Several studies in chronic liver disease (CLD) have determined a good accuracy of TE in predicting significant fibrosis and an optimal accuracy in...

  • Liver Stiffness Measurements in Patients with Different Stages of Nonalcoholic Fatty Liver Disease: Diagnostic Performance and Clinicopathological Correlation. Kumar, Ramesh; Rastogi, Archana; Sharma, Manoj; Bhatia, Vikram; Tyagi, Pankaj; Sharma, Praveen; Garg, Hitendra; Chandan Kumar, K.; Bihari, Chhagan; Sarin, Shiv // Digestive Diseases & Sciences;Jan2013, Vol. 58 Issue 1, p265 

    Background: The present study evaluated performance characteristics of liver stiffness measurement (LSM) by FibroScan in patients with different stages of nonalcoholic fatty liver disease (NAFLD). Patients and Methods: A total of 307 subjects (120 NAFLD, 85 NAFLD related cirrhosis, and 102...

  • Rupture of the Liver Associated with Acute Fatty Liver of Pregnancy. Minuk, G. Y.; Kelly, J. K.; Lui, R. C. // American Journal of Gastroenterology;May1987, Vol. 82 Issue 5, p457 

    Describes a case of a patient with rupture of the liver associated with acute fatty liver during pregnancy. Disease symptoms observed on the patient; Maternal blood pressure of the patient before surgery; Pathological description of the biopsy obtained from the liver of the patient.

  • Corrections.  // Gut;Aug2015, Vol. 64 Issue 8, p137 

    A correction to the article "Pathobiology of Liver Fibrosis †A Translational Success Story" by Y. A. Lee that was published in a 2015 issue of the periodical is presented.

  • Corrections.  // Gut;Aug2015, Vol. 64 Issue 8, p1337 

    A correction to the article "Pathobiology of Liver Fibrosis - A Translational Success Story" by Y. A. Lee that was published in a 2015 issue of the periodical is presented.

  • Assessment of Liver Fibrosis: Noninvasive Means. Poynard, Thierry; Morra, Rachel; Ingiliz, Patrick; Imbert-Bismut, Françoise; Thabut, Dominique; Messous, Djamila; Munteanu, Mona; Massard, Julien; Benhamou, Yves; Ratziu, Vlad // Saudi Journal of Gastroenterology;Oct2008, Vol. 14 Issue 4, p163 

    Liver biopsy, owing to its limitations and risks, is an imperfect gold standard for assessing the severity of the most frequent chronic liver diseases chronic hepatitis C (HCV), B (HBV) non alcoholic (NAFLD) and alcoholic (ALD) fatty liver diseases. This review summarizes the advantages and the...


Read the Article


Sign out of this library

Other Topics